3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30555227 | Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment. | 2018 | 1 |
| 2 | 28500233 | Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation. | 2017 Jul | 1 |
| 3 | 24222661 | Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo. | 2013 Dec | 2 |